The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Albumin–drug interaction and its clinical implication
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
All About Albumin: Biochemistry, Genetics, and Medical Applications
Peters, T. (1995) · Thammasat University Digital Collections · Cited by 3,372
Carter, D. C., & Ho, J. X. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60640-3 · Cited by 3,187
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., & Curry, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.07.075 · Cited by 1,941
Self-citationHuman serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 1,931
Crystal structure of human serum albumin at 2.5 Å resolution
Sugio, S., Kashima, A., Mochizuki, S., Noda, M., & Kobayashi, K. (1999) · Protein Engineering, Design and Selection · doi:10.1093/protein/12.6.439 · Cited by 1,786
The Characterization of Two Specific Drug Binding Sites on Human Serum Albumin
SUDLOW, G., BIRKETT, D. J., & WADE, D. N. (1975) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10691-3 · Cited by 1,725
Further Characterization of Specific Drug Binding Sites on Human Serum Albumin
SUDLOW, G., BIRKETT, D. J., & WADE, D. N. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10855-9 · Cited by 1,443
Curry, S., Mandelkow, H., Brick, P., & Franks, N. (1998) · Nature Structural Biology · doi:10.1038/1869 · Cited by 1,377
Bhattacharya, A. A., Grüne, T., & Curry, S. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4158 · Cited by 905
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
Smith, D. A., Di, L., & Kerns, E. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3287 · Cited by 898
Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin.
Kragh-Hansen, U., Chuang, V. T. G., & Otagiri, M. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.695 · Cited by 892
Self-citationCytochrome P4502C9: an enzyme of major importance in human drug metabolism
Miners, J. O., & Birkett, D. J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00721.x · Cited by 844
Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin
Petitpas, I., Bhattacharya, A. A., Twine, S., East, M., & Curry, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100575200 · Cited by 825
Stange, Mitzner, Risler, Erley, Lauchart, Goehl, Klammt, S., Peszynski, Freytag, Hickstein, et al. (1999) · Artificial Organs · doi:10.1046/j.1525-1594.1999.06122.x · Cited by 604
Binding of the General Anesthetics Propofol and Halothane to Human Serum Albumin
Bhattacharya, A. A., Curry, S., & Franks, N. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005460200 · Cited by 529
Binding of Drugs to Human Serum Albumin:
Sjöholm, I., Ekman, B., Kober, A., Ljungstedt-Påhlman, I., Seiving, B., & Sjödin, T. (1979) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13820-0 · Cited by 474
Sjöholm, I., Ekman, B., Kober, A., et al. (1979) · PubMed · Cited by 447
Binding of Drugs to Serum Albumin
Koch-Weser, J., & Sellers, E. M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602052940605 · Cited by 410
Plasma and Tissue Protein Binding of Drugs in Pharmacokinetics
Jusko, W. J., & Gretch, M. (1976) · Drug Metabolism Reviews · doi:10.3109/03602537608995839 · Cited by 372
The Binding of Drugs by Plasma Proteins
Meyer, M. C., & Guttman, D. E. (1968) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600570601 · Cited by 370
Clinical pharmacokinetics and phamacodynamics: concepts and applications
Rowland, M., & Tozer, T. N. (2011) · Cited by 367
Cisplatin Binding Sites on Human Albumin
Ivanov, A. I., Christodoulou, J., Parkinson, J. A., Barnham, K. J., Tucker, A., Woodrow, J., & Sadler, P. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.14721 · Cited by 362
Oettl, K., & Stauber, R. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707251 · Cited by 357
Binding of Drugs by Albumin Plasma Protein
Vallner, J. J. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660402 · Cited by 335
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
Schmidt, S., Gonzalez, D., & Derendorf, H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21916 · Cited by 335
Rolan, P. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04251.x · Cited by 301
Lessons from the Crystallographic Analysis of Small Molecule Binding to Human Serum Albumin
Curry, S. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.342 · Cited by 298
Basic clinical pharmacokinetics
Winter, M. E. (1980) · Cited by 285
Sen, S., Davies, N. A., Mookerjee, R. P., Cheshire, L. M., Hodges, S. J., Williams, R., & Jalan, R. (2004) · Liver Transplantation · doi:10.1002/lt.20236 · Cited by 284
Simard, J. R., Zunszain, P. A., Ha, C.-E., Yang, J. S., Bhagavan, N. V., Petitpas, I., Curry, S., & Hamilton, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506440102 · Cited by 271
Crystallographic Analysis of Human Serum Albumin Complexed with 4Z,15E-Bilirubin-IXα
Zunszain, P. A., Ghuman, J., McDonagh, A. F., & Curry, S. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.06.016 · Cited by 267
Yamasaki, K., Maruyama, T., Kragh-Hansen, U., & Otagiri, M. (1996) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(96)00013-1 · Cited by 264
Self-citationMITZNER, S. R., STANGE, J., KLAMMT, S., PESZYNSKI, P., SCHMIDT, R., & NO[Combining Diaeresis]LDGE-SCHOMBURG, G. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12suppl_1s75 · Cited by 263
Doweiko, J. P., & Nompleggi, D. J. (1991) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607191015004476 · Cited by 256
Laleman, W., Wilmer, A., Evenepoel, P., Elst, I. V., Zeegers, M., Zaman, Z., Verslype, C., Fevery, J., & Nevens, F. (2006) · Critical Care · doi:10.1186/cc4985 · Cited by 250
Potentiation of Anticoagulant Effect of Warfarin by Phenylbutazone
Aggeler, P. M., O'Reilly, R. A., Leong, L., & Kowitz, P. E. (1967) · New England Journal of Medicine · doi:10.1056/nejm196703022760904 · Cited by 236
A Molecular Functional Study on the Interactions of Drugs with Plasma Proteins
Otagiri, M. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.309 · Cited by 228
Self-citationClinically Important Drug Interactions with Anticoagulants: An Update
Harder, S., & Thürmann, P. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630060-00002 · Cited by 227
Update on the Pharmacokinetics and Redox Properties of Protein-Bound Uremic Toxins
Watanabe, H., Miyamoto, Y., Otagiri, M., & Maruyama, T. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22592 · Cited by 145
Self-citationMera, K., Anraku, M., Kitamura, K., Nakajou, K., Maruyama, T., & Otagiri, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.035 · Cited by 145
Self-citationZhu, L., Yang, F., Chen, L., Meehan, E. J., & Huang, M. (2008) · Journal of Structural Biology · doi:10.1016/j.jsb.2007.12.004 · Cited by 137
Fehske, K. J., Schläfer, U., Wollert, U., et al. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14614-2 · Cited by 136
Characterization of Binding Site of Uremic Toxins on Human Serum Albumin.
Sakai, T., Takadate, A., & OTAGIRI, M. (1995) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.18.1755 · Cited by 136
Self-citationKragh‐Hansen, U. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09363-0 · Cited by 130
Crystallographic analysis reveals a unique lidocaine binding site on human serum albumin
Hein, K. L., Kragh‐Hansen, U., Morth, J. P., Jeppesen, M. D., Otzen, D. E., MØLLER, J. V., & Nissen, P. (2010) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.03.014 · Cited by 126
Clinical pharmacokinetics and pharmacodynamicsconcepts and applications
Rowland, M. (2009) · Cited by 119
Relations between high-affinity binding sites of markers for binding regions on human serum albumin
Kragh‐Hansen, U. (1985) · Biochemical Journal · doi:10.1042/bj2250629 · Cited by 115
Honoré, B., & Brodersen, R. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15032-3 · Cited by 107
Location and characterization of the warfarin binding site of human serum albumin
Bos, O. J. M., Remijn, J. P. M., Fischer, M. J. E., Wilting, J., & Janssen, L. H. M. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90072-x · Cited by 83
Impaired drug-binding capacities of in vitro and in vivo glycated albumin
Baraka-Vidot, J., Guérin-Dubourg, A., Bourdon, E., & Rondeau, P. (2012) · Biochimie · doi:10.1016/j.biochi.2012.05.017 · Cited by 80
Komatsu, K., Ito, K., Nakajima, Y., Kanamitsu, S.-I., Imaoka, S., Funae, Y., Green, C. E., Tyson, C. A., Shimada, N., & Sugiyama, Y. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15066-0 · Cited by 74
Abnormal serum protein binding of acidic drugs in diabetes mellitus
Ruiz‐Cabello, F., & Erill, S. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.241 · Cited by 73
Karvellas, C. J., Gibney, R. T. N., Kutsogiannis, D. J., Wendon, J. A., & Bain, V. G. (2007) · Critical Care · doi:10.1186/cc5922 · Cited by 67
Damsten, M. C., Commandeur, J. N. M., Fidder, A., Hulst, A. G., Touw, D. J., Noort, D., & Vermeulen, N. P. E. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.014233 · Cited by 66
Bos, O. J. M., Fischer, M. J. E., Wilting, J., & Janssen, L. H. M. (1988) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(88)90007-6 · Cited by 55
Kortgen, A., Rauchfuß, F., Götz, M., Settmacher, U., Bauer, M. W., & Sponholz, C. (2009) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2009.00760.x · Cited by 50
Takahashi, H., Kashima, T., Kimura, S., Murata, N., Takaba, T., Iwade, K., Abe, T., Tainaka, H., Yasumori, T., & Echizen, H. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15043-x · Cited by 45
Ryan, A. J., Chung, C., & Curry, S. (2011) · BMC Structural Biology · doi:10.1186/1472-6807-11-18 · Cited by 38
Azapropazone binding to human serum albumin
Fehske, K. J., J�hnchen, E., M�ller, W. E., et al. (1980) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00498574 · Cited by 23
Bertucci, C., Nanni, B., Raffaelli, A., & Salvadori, P. A. (1998) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(98)00163-0 · Cited by 22
Karvellas, C. J., Bagshaw, S. M., McDermid, R. C., Stollery, D. E., & Gibney, R. T. N. (2008) · The International Journal of Artificial Organs · doi:10.1177/039139880803100511 · Cited by 18
Narazaki, R., & Otagiri, M. (1997) · Pharmaceutical Research · doi:10.1023/a:1012006306915 · Cited by 16
Self-citationOgata, K., Takamura, N., Tokunaga, J., Kawai, K., Arimori, K., & Higuchi, S. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.1.0002 · Cited by 13
Minomo, A., Ishima, Y., Chuang, V. T. G., Suwa, Y., Kragh‐Hansen, U., Narisoko, T., Morioka, H., Maruyama, T., & Otagiri, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.01.006 · Cited by 13
Self-citationDasgupta, A., & Havlik, D. M. (1998) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199812000-00013 · Cited by 11
Ōsawa, M., Hada, N., Matsumoto, K., et al. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.009 · Cited by 10
Cited by
Human serum albumin, systemic inflammation, and cirrhosis
Arroyo, V., García-Martinez, R., & Salvatella, X. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.012 · Cited by 560
Albumin and its application in drug delivery
Sleep, D. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.993313 · Cited by 464
Albumin nanostructures as advanced drug delivery systems
Karimi, M., Bahrami, S., Ravari, S. B., Zangabad, P. S., Mirshekari, H., Bozorgomid, M., Shahreza, S., Sori, M., & Hamblin, M. R. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1193149 · Cited by 422
Serum albumin in health and disease: esterase, antioxidant, transporting and signaling properties
Belinskaia, D. A., Voronina, P. A., Shmurak, V. I., Jenkins, R. O., & Goncharov, N. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910318 · Cited by 416
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 385
Metadata
- Authors
- Yamasaki, K., Chuang, V. T. G., Maruyama, T., & Otagiri, M.
- Venue
- Biochimica et Biophysica Acta (BBA) - General Subjects
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 1830
- Issue
- 12
- Pages
- 5435-5443
- ISSN
- 0304-4165 (ISSN-L)
- OpenAlex
- W1995666127
- Cited by
- 464
- References
- 66
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.